OMCL Omnicell, Inc.

NASDAQ
$36.65

Omnicell, Inc. (OMCL) is expected to report earnings on January 28, 2027, before the market open. The consensus earnings estimate is $0.03 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of +2.0% since its last earnings release on October 29, 2026.

Omnicell Beat Expectations, Provides Mixed Guidance
Thursday, October 29, 2026 · 6:30 AM ET
Earnings Date
4th Quarter, Dec 2026
Jan 28
Thursday · 6:30 AM ET
Earnings Whisper
-
vs $0.03 (GAAP)
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $36.77

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About Omnicell, Inc.

Omnicell, Inc., provides automation & business information solutions to update medication administration process & manage costly medical supplies for operational efficiency & patient safety. Its operating business segments are acute care & non-acute care.

Sector

Healthcare

Industry

Medical Instruments/Supply

Held By 3 ETFs, by dollar flow

Charts powered in part by Lightweight Charts™ by TradingView.